What is Vivid Pathology?
Vivid Pathology operates as a specialized pathology group, distinguished by its nearly 50 years of experience in delivering high-quality, patient-centric diagnostic services. The company focuses on key medical specialties including dermatopathology, gastrointestinal pathology, hematopathology, and women's health. Vivid Pathology's commitment to timely and accurate results is supported by a team of nine board-certified physicians, ensuring precise diagnoses and effective communication with referring physicians. Their operational model is designed to provide accessible healthcare solutions to patients nationwide, irrespective of their geographical location.
How much funding has Vivid Pathology raised?
Vivid Pathology has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
Key Investors in Vivid Pathology
PPP
Public-Private Partnership
What's next for Vivid Pathology?
The recent large-scale late-stage funding indicates Vivid Pathology is poised for significant growth and strategic initiatives. This capital infusion is likely to support the expansion of its service offerings, technological advancements in diagnostic capabilities, and potentially broader market penetration. The company's focus on subspecialized pathology, combined with its long-standing reputation for quality and efficiency, positions it favorably to capitalize on evolving healthcare demands and further solidify its market leadership.
See full Vivid Pathology company page
